Roth Mkm Cuts Aspen Aerogels (NYSE:ASPN) Price Target to $3.00

Aspen Aerogels (NYSE:ASPN) had its price objective lowered by Roth Mkm from $6.00 to $3.00 in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the construction company’s stock.

Several other equities analysts have also recently issued reports on ASPN. TD Cowen dropped their price objective on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday. Barclays dropped their price target on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels has an average rating of “Hold” and a consensus target price of $4.50.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $3.13 on Thursday. The stock’s 50-day moving average price is $3.32 and its 200 day moving average price is $5.03. The company has a quick ratio of 3.33, a current ratio of 3.94 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $258.36 million, a PE ratio of -0.66 and a beta of 2.99. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.78.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.07). Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The company had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. During the same quarter last year, the business posted $0.14 earnings per share. The company’s revenue for the quarter was down 66.4% compared to the same quarter last year. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. As a group, equities research analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

Institutional Trading of Aspen Aerogels

Several large investors have recently bought and sold shares of ASPN. Vanguard Group Inc. increased its position in shares of Aspen Aerogels by 0.5% in the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock valued at $31,392,000 after buying an additional 22,686 shares in the last quarter. Needham Investment Management LLC grew its stake in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after acquiring an additional 912,000 shares during the last quarter. Invesco Ltd. increased its holdings in Aspen Aerogels by 237.9% during the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after acquiring an additional 2,907,558 shares in the last quarter. State Street Corp raised its position in Aspen Aerogels by 28.6% during the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock worth $7,079,000 after acquiring an additional 556,833 shares during the last quarter. Finally, Federated Hermes Inc. acquired a new position in Aspen Aerogels during the second quarter worth about $10,459,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.